C4B and prostate carcinoma: Finally, although multi-omics approaches have unveiled the correlations among the gut microbiota, metabolites, and gene expression, to establish a definitive causal relationship, further in vivo and in vitro experiments are required to validate the microbiota and their metabolites identified in this study that are strongly associated with CH’s inhibition of prostate cancer.